These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid. Reeves EKM; Hoffman EP; Nagaraju K; Damsker JM; McCall JM Bioorg Med Chem; 2013 Apr; 21(8):2241-2249. PubMed ID: 23498916 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects. Du J; Cheng B; Zhu X; Ling C J Immunol; 2011 Jul; 187(2):942-50. PubMed ID: 21666059 [TBL] [Abstract][Full Text] [Related]
4. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism. Vanden Berghe W; Francesconi E; De Bosscher K; Resche-Rigon M; Haegeman G Mol Pharmacol; 1999 Oct; 56(4):797-806. PubMed ID: 10496964 [TBL] [Abstract][Full Text] [Related]
5. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084 [TBL] [Abstract][Full Text] [Related]
6. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation. Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663 [TBL] [Abstract][Full Text] [Related]
7. Potential Dissociative Glucocorticoid Receptor Activity for Protopanaxadiol and Protopanaxatriol. Karra AG; Konstantinou M; Tzortziou M; Tsialtas I; Kalousi FD; Garagounis C; Hayes JM; Psarra AG Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591629 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. De Bosscher K; Schmitz ML; Vanden Berghe W; Plaisance S; Fiers W; Haegeman G Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13504-9. PubMed ID: 9391055 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the rat UGT1A6 by glucocorticoids involves a cryptic glucocorticoid response element. Falkner KC; Ritter JK; Prough RA Drug Metab Dispos; 2008 Feb; 36(2):409-17. PubMed ID: 18039810 [TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. Chantong B; Kratschmar DV; Nashev LG; Balazs Z; Odermatt A J Neuroinflammation; 2012 Nov; 9():260. PubMed ID: 23190711 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells. Dvorák Z; Vrzal R; Maurel P; Ulrichová J Chem Biol Interact; 2006 Feb; 159(2):117-28. PubMed ID: 16289013 [TBL] [Abstract][Full Text] [Related]
12. Transrepression and transactivation potencies of inhaled glucocorticoids. Dirks NL; Li S; Huth B; Hochhaus G; Yates CR; Meibohm B Pharmazie; 2008 Dec; 63(12):893-8. PubMed ID: 19177906 [TBL] [Abstract][Full Text] [Related]
13. PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB. Bougarne N; Paumelle R; Caron S; Hennuyer N; Mansouri R; Gervois P; Staels B; Haegeman G; De Bosscher K Proc Natl Acad Sci U S A; 2009 May; 106(18):7397-402. PubMed ID: 19376972 [TBL] [Abstract][Full Text] [Related]
14. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Salter M; Biggadike K; Matthews JL; West MR; Haase MV; Farrow SN; Uings IJ; Gray DW Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L660-7. PubMed ID: 17575011 [TBL] [Abstract][Full Text] [Related]
16. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. Liden J; Delaunay F; Rafter I; Gustafsson J; Okret S J Biol Chem; 1997 Aug; 272(34):21467-72. PubMed ID: 9261164 [TBL] [Abstract][Full Text] [Related]
17. α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes. Zhao X; Khurana S; Charkraborty S; Tian Y; Sedor JR; Bruggman LA; Kao HY J Biol Chem; 2017 Feb; 292(5):1637-1647. PubMed ID: 27998979 [TBL] [Abstract][Full Text] [Related]
18. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Ray KP; Farrow S; Daly M; Talabot F; Searle N Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):707-15. PubMed ID: 9371735 [TBL] [Abstract][Full Text] [Related]